On January 10, CDC released a revised interim VIS for varicella. It includes changes to reflect the new two-dose schedule for children and the availability of the measles-mumps-rubella- varicella (MMRV) vaccine. After ACIP publishes these updated recommendations in MMWR, a final varicella VIS will be developed.